Clicky

Valneva SE(VALN)

Description: Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.


Keywords: Medicine Infectious Diseases Vaccines Vaccination Virology Medical Research Lyme Disease Valneva Se

Home Page: valneva.com

VALN Technical Analysis

6 rue Alain Bombard
Saint-Herblain, 44800
France
Phone: 33 2 28 07 37 10


Officers

Name Title
Mr. Thomas Lingelbach Chairman of the Management Board, Pres & CEO
Mr. Franck Grimaud MBA Director Gen., Chief Bus. Officer & Member of Management Board
Mr. Frederic Jacotot VP of Legal & IP, Gen. Counsel, Corp. Sec. and Member of Management Board
Dr. Juan-Carlos Jaramillo M.D. Chief Medical Officer & Member of the Management Board
Mr. Peter Buhler CFO & Management Board Member
Mr. Perry Celentano Interim Chief Operating Officer
Ms. Dipal Patel Chief Commercial Officer & Member of Management Board
Mr. Joshua Drumm Ph.D. VP of Investor Relations
Ms. Laetitia Bachelot-Fontaine VP of Global Communications & European Investor Relations
Mr. Gerald Strohmaier VP of Human Resource

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 7.7705
Price-to-Book MRQ: 5.7635
Price-to-Sales TTM: 2.0179
IPO Date: 2021-05-05
Fiscal Year End: December
Full Time Employees: 762
Back to stocks